Home Expensive Hepatitis C Cure Raises Tough Questions
 

Keywords :   


Expensive Hepatitis C Cure Raises Tough Questions

2015-05-18 13:45:13| Biotech - Topix.net

In some quarters, it is known as the Sovaldi Squeeze: on one side, the urgent need to treat a disease, and on the other, the budget-crippling cost of doing so. Connecticut, like other states, is caught in the middle.

Tags: questions expensive tough cure

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.06Horizon expert 'gave evidence based on informal chats'
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
26.06Beckers Commits to Widespread Science Based Targets
26.06PPG to Announce Second-quarter 2024 Results July 18
26.06Fresh Coat for First Responders: New Hampshire Fire Station Gets a Makeover by California Paints
26.06Michigan Sets Record Recycling Rate in 2023, Recycles Nearly 70,000 Tons of Materials
26.06Companies Seek Federal EPR: How Producers Can Prepare
26.06Q&A with GFLs Tyler Stefure: Integrating New Fleet Tech & Upholding GFL Values
More »